The Sedative Effects of Dexmedetomidine VS Propofol During Peribulbar Anesthesia in Patients Undergoing Vitrectomy Surgery

Launched by BENI-SUEF UNIVERSITY · Apr 11, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two different sedatives, Dexmedetomidine and Propofol, affect patients during a specific type of eye surgery called vitrectomy. The goal is to see which sedative offers better comfort and satisfaction for patients while monitoring their heart and breathing, recovery time, pain relief, mental function after surgery, and any side effects that may occur.

To participate in this trial, you need to be between 20 and 70 years old and have surgery expected to last less than 2 hours. However, some people may not be eligible, such as those with certain mental health issues, allergies to the study medications, or specific health conditions like severe heart or lung diseases. If you join the study, you will receive either Dexmedetomidine or Propofol during your surgery, and researchers will closely monitor your experience to gather information on how well each sedative works. This trial is currently recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 20-70 years.
• • Expected time of surgery less than 2 hours
• Exclusion Criteria:
• • patients with an initial mini mental state examination (MMSE) score less than 23
• • Patients refusing LA
• • Clotting abnormalities
• • Impaired mental status
• • Allergy to any of the study medications
• • Also, patients were excluded if they had severe cardiac disease, chronic obstructive lung disease, a history of sleep apnea and those who received general anesthesia.